Wells Fargo: Nvidia's H200 Sales to China Are Limited in Scale
Taylor Wilson
Wells Fargo analyst Aaron Rakers estimates Nvidia's H200 shipments to China at roughly 200,000 units worth $6–8 billion, calling it only a "modest incremental positive" — far below what some bullish expectations imply.
What is Wells Fargo's actual call?
Rakers maintains an overweight rating on Nvidia but flags H200 China sales as limited in scale.
He estimates about 200,000 units at an ASP of roughly $35,000–$40,000, yielding $6–8 billion in revenue.
This means → even if the China market opens fully, this revenue would be a modest slice of Nvidia's annual top line.
Why does Rakers say the market has "no expectation" priced in?
His core argument: investor sentiment and Nvidia's stock price have not priced in any anticipated H200 China sales.
In plain terms = the market never treated this as an upside catalyst, so even confirmed sales are unlikely to move the stock much.
He labels it a "modest incremental positive" — better than nothing, but not a game-changer.
Where does the policy actually stand?
President Trump approved Nvidia's H200 shipments to China last December; the decision took effect in January and received final clearance in May.
Yet Chinese regulators have not formally approved customer purchases — only multiple reports suggesting approval is imminent.
This means → the U.S. side has cleared the path, but China's side has not stamped it — a bilateral timing gap persists.
Even if approved, how can China use these chips?
Reports this week indicate China will allow top AI firms to buy H200s on a limited basis, restricted to model training only.
Inference workloads must still be handled by domestic Chinese GPU makers; Nvidia cannot serve the full stack.
In plain terms = China would buy only the "training" slice of compute; day-to-day model inference stays on homegrown chips.
What does this mean for investors?
Wells Fargo's conclusion is blunt: H200 China sales are not a variable that changes the Nvidia investment thesis.
The two things to watch are the pace of policy implementation and actual procurement volumes.
This reflects a market that has turned conservative on U.S.–China chip trade — the upside window has narrowed considerably.
Content is for reference only, not financial advice.